We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

How Has the Pharmaceutical Manufacturing Market Growth Performance Trended Historically, And What Lies Ahead?

The size of the pharmaceutical manufacturing market has seen a substantial increase recently. It is anticipated to escalate from $519.78 billion in 2024 to $573.95 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. Factors driving this growth during the historical period include a rise in global health complications, an upturn in healthcare expenditure, an expanding requirement for generic drugs, the expiry of patents for top-selling drugs, and the growth in the capacity of pharmaceutical production.

In the coming years, the pharmaceutical manufacturing market size is projected to experience swift expansion, reaching $846.74 billion in 2029 with a 10.2% compound annual growth rate (CAGR). Factors contributing to the growth in this projected period include the rise of personalized medicine, increasing older population, surging demand for biosimilars, support from the government for local production, and the growing prevalence of chronic diseases. Major trends for the forecast period encompass advancements in ongoing manufacturing, the incorporation of artificial intelligence, embracing smart manufacturing technologies, innovations in the production of biologics, and an emphasis on research and development efficiency.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24375&type=smp

What Are the Core Market Drivers Propelling Growth in the Pharmaceutical Manufacturing Industry?

The pharmaceutical manufacturing market is projected to expand due to the growing incidence of chronic diseases. These are health issues that typically evolve gradually and persist for at least a year, often necessitating continued medical care or hindering daily activities. The rise in chronic ailments is driven by increased life expectancy, lack of physical activity, and poor dietary patterns, which in turn stimulates the demand for sustainable healthcare remedies and preventative wellness strategies. Pharmaceutical manufacturing plays a crucial role for chronic diseases as it assures a regular provision of vital drugs, fosters innovation in drug manufacturing, and fulfils the escalating requirement for efficient long-term treatment options. For instance, the National Health Service, a government department in the UK, indicated in September 2024 that 11% of adults 35 or above are suffering from advanced chronic kidney disease, with both prevalence and severity increasing with age. Approximately 48% of individuals aged 75 and older suffer from this disease to some degree, and another 36% are in more severe stages. Consequently, the increasing incidence of chronic diseases is fuelling the surge in the pharmaceutical manufacturing market.

How Is the Pharmaceutical Manufacturing Market Segmented?

The pharmaceutical manufacturing market covered in this report is segmented –

1) By Molecule Type: Biologics And Biosimilars, Conventional Drugs

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Route Of Administration: Oral, Topical, Parenteral, Inhalations, Other Route Of Administrations

4) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

5) By Sales Channel: Retail, Non-retail

Subsegments:

1) By Biologics And Biosimilars: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell Therapies, Gene Therapies, Hormones, Blood And Plasma Products

2) By Conventional Drugs: Analgesics, Antipyretics, Antibiotics, Antivirals, Antifungals, Antihypertensives, Antidepressants, Antidiabetics

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24375&type=smp

Which Regions Are Driving the Next Phase of the Pharmaceutical Manufacturing Market Growth?

North America was the largest region in the pharmaceutical manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Pharmaceutical Manufacturing Industry?

Leading pharmaceutical manufacturing market players are concentrating on the creation of sophisticated solutions such as fully automated Radioligand Therapy (RLT) manufacturing facilities. This is being done to improve production efficiency, maintain high-quality standards, and satisfy the increasing demand for targeted cancer treatments. An automated RLT facility is a modern production environment that employs cutting-edge automation technologies to simplify and enhance radioligand therapy production, guaranteeing steady, efficient, and scalable manufacturing. For example, in January 2024, Swiss-based pharma corporation Novartis AG gained approval from the US Food and Drug Administration (FDA) for producing Pluvicto in a new generation RLT manufacturing facility based in Indianapolis. This will considerably boost their production capacity for radioligand therapy drugs, including Pluvicto and Lutathera. Novartis is implementing this expansion as a part of their broader strategy to match the surging global demand for targeted cancer treatments and enhance patient access globally.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-manufacturing-global-market-report

How Is the Pharmaceutical Manufacturing Market Defined and What Are Its Core Parameters?

Pharmaceutical manufacturing is the industrial process of developing, producing, and packaging medications and medical products at scale through chemical synthesis, biological processing, and formulation of active and inactive ingredients, carried out under stringent regulatory and quality control standards to ensure the safety, efficacy, consistency, and compliance of drugs intended for human and veterinary use across global healthcare systems.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24375&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model